Personalized Heart Failure Treatment Adjustment Study
Part of Heart & circulation clinical trials.
This study helps doctors adjust heart failure medications based on your individual response and biomarkers (blood markers). If your heart isn't pumping well enough and you're not yet on the full recommended dose of heart failure medications, this trial may help optimize your treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with new or worsening heart failure where the heart's main pumping chamber (left ventricle) pumps less than 50% of blood with each beat
- Currently taking a diuretic (water pill) like furosemide at a dose of 40 mg or more per day
- Taking less than 50% of the recommended target dose of at least one standard heart failure medication
- Your doctor plans to increase your heart failure medications
- Not on kidney dialysis and not intolerant to multiple classes of heart failure drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a combination of biomarkers can help personalize treatment for people with a specific type of heart failure called HFpEF (or heart failure with preserved ejection fraction). It aims to find better treatments based on your individual test results.
This trial tests a virtual “heart failure clinic” and home heart monitoring to help people manage symptoms and outcomes. It may help by catching problems earlier and guiding safer self-care between doctor visits.
This trial tests a device to help the kidneys remove excess fluid in people hospitalized for worsening heart failure who are not responding well to standard diuretic (water pill) therapy. It aims to improve heart and kidney function.
This study tests a new diagnostic toolkit that uses blood markers to help doctors personalize heart failure treatment. The goal is to better manage your symptoms and reduce hospitalizations.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.